Results 71 to 80 of about 485 (159)
Pollen from Brazilian Savannah (Cerrado), Mato Grosso do Sul state.
Ariadne Barbosa Gonçalves (788714)
core +1 more source
Migraines: unraveling the mystery [PDF]
Migraine is a prevalent and complex neurological disorder that significantly impacts the quality of life of affected individuals. This paper explores the pathophysiology, classification, and treatment options for migraine.
Librić, Lukas
core +1 more source
PurposeThis study aimed to develop and validate a novel web-based calculator using machine learning algorithms to predict fragility fracture risk in People living with HIV (PLWH), who face increased morbidity and mortality from such fractures.MethodWe retrospectively analyzed clinical data from Beijing Ditan Hospital orthopedic department between 2015 ...
Bo Liu +5 more
openaire +3 more sources
Primary headache disorders:Five new things
Purpose of review: To review 5 new areas in primary headache disorders, especially migraine and cluster headache. Recent findings: Calcitonin gene-related peptide (CGRP) receptor antagonists (gepants - rimegepant and ubrogepant) and serotonin 5-HT1F ...
Goadsby, Peter J.; id_orcid
core +1 more source
Receptors for the Acute Therapy of Migraine: A Literature Review
Objective: To review and highlight current literature on emerging acute migraine treatments, focusing on CGRP receptor antagonists, gepants, and 5-HT1F receptor agonists (ditans).
Villar-Martínez, María Dolores +7 more
core +1 more source
Les nouveaux traitements antimigraineux
La migraine est la deuxième cause d’invalidité dans le monde et la première chez les personnes âgées de moins de 50 ans. En France, 20 % de la population est touchée par ce fléau et les traitements disponibles ont une efficacité variable, parmi lesquels ...
Chung, Alexandre
core
Beyond the Guidelines: A Narrative Review of Treatments on the Horizon for Migraine in Children and Adolescents. [PDF]
VanderPluym JH +4 more
europepmc +1 more source
Objective: The Greek Society of Migraine and Headache Patients conducted its third in-line population web-based survey in 2023 to ascertain if the burden of the disease and the patients’ satisfaction with conventional and novel migraine therapies ...
Konstantinos Bilias +8 more
core +1 more source

